Clinical Trials in Hampton, Virginia
15 recruiting
Showing 1–15 of 15 trials
Recruiting
Phase 2Phase 3
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell CarcinomaStage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7+6 more
National Cancer Institute (NCI)613 enrolled341 locationsNCT01810913
Recruiting
Phase 2Phase 3
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis
End-stage Kidney DiseaseAtherosclerotic Cardiovascular DiseaseAtherosclerotic Cardiovascular Disease in Patients With ESKD
CSL Behring2,310 enrolled542 locationsNCT05485961
Recruiting
Not Applicable
Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response
Chronic Low-back Pain
VA Office of Research and Development2,529 enrolled19 locationsNCT04142177
Recruiting
Phase 3
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
Coronavirus Disease (COVID-19)
Merck Sharp & Dohme LLC3,082 enrolled222 locationsNCT06667700
Recruiting
Phase 2Phase 3
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
Gastroesophageal-junction CancerEsophageal AdenocarcinomaMetastatic Gastric Cancer+1 more
Pfizer840 enrolled58 locationsNCT07392892
Recruiting
Phase 2
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Loxo Oncology, Inc.249 enrolled133 locationsNCT06588478
Recruiting
Phase 2
A Study to Evaluate Solrikitug in Participants With COPD (ZION)
COPD
Uniquity One (UNI)171 enrolled118 locationsNCT06496620
Recruiting
Phase 2
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
Metastatic Urothelial Cancer
Gilead Sciences827 enrolled135 locationsNCT03547973
Recruiting
Phase 4
A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)
ModernaTX, Inc.30,000 enrolled150 locationsNCT07266558
Recruiting
Phase 2
A Study to Evaluate Solriktug in Adult Participants With Asthma
Asthma
Uniquity One (UNI)140 enrolled74 locationsNCT06496607
Recruiting
Phase 4
A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder
Opioid-use Disorder
VA Office of Research and Development952 enrolled25 locationsNCT04375033
Recruiting
Not Applicable
ERP to Improve Functioning in Veterans With OCD
Obsessive Compulsive Disorder (OCD)Comorbid Post-Traumatic Stress Disorder and OCD
VA Office of Research and Development160 enrolled18 locationsNCT05240924
Recruiting
Registry Study for Radiation Therapy Outcomes
Neoplasms
Proton Collaborative Group40,000 enrolled29 locationsNCT01255748
Recruiting
Phase 2
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
Breast CancerBreast NeoplasmCancer of the Breast+1 more
Proton Collaborative Group132 enrolled9 locationsNCT01766297
Recruiting
Phase 3
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
Prostate Cancer
Proton Collaborative Group192 enrolled4 locationsNCT01492972